Physician profile
Soyini Mattis Hawkins
NPI 1134388945
$585,472.40
in general payments reported to CMS, 2019-2025
40 companies · $47K in 2025
The $47K reported for 2025 was more than what 99% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $94K · 2020: $37K · 2021: $149K · 2022: $138K · 2023: $70K · 2024: $51K · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $105K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Travel and Lodging: $22K · Education: $8,606 · Food and Beverage: $4,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $104,910.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,660.00 |
| Travel and Lodging | $21,924.92 |
| Education | $8,606.25 |
| Food and Beverage | $4,250.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $236,482.90 | 2019-2025 | |
| Acessa Health INC. | $208,711.16 | 2019-2025 | Acessa Provu System |
| Myovant Sciences INC. | $42,358.97 | 2021-2022 | |
| Pfizer INC. | $35,777.32 | 2021-2024 | |
| Hologic Sales and Service, LLC | $23,440.74 | 2019-2025 | Acessa Provu System, Novasure, Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $21,453.77 | 2023-2025 | Myfembree, Gemtesa |
| Olympus Corporation of The Americas | $9,488.53 | 2024 | Olympus |
| Cytyc Surgical Products, LLC | $1,730.55 | 2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Myosure Tissue Removal Device |
| Coopersurgical, INC. | $1,721.73 | 2019-2023 | Mara Console |
| Bayer Healthcare Pharmaceuticals INC. | $917.46 | 2020-2022 | |
| Gynesonics, INC. | $682.55 | 2021-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Asensus Surgical, INC. | $456.24 | 2019 | |
| Intuitive Surgical, INC. | $311.35 | 2024-2025 | |
| Baxter Healthcare | $215.18 | 2019-2025 | Perclot, Tisseel, Seprafilm |
| Astellas Pharma US INC | $214.88 | 2019-2025 | Veozah |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $165.96 | 2019-2022 | |
| Daiichi Sankyo INC. | $152.58 | 2020-2023 | Injectafer |
| Evofem Biosciences, INC. | $138.62 | 2021-2025 | Phexxi, Solosec, Phexx |
| Thd America, INC. | $136.65 | 2020-2023 | |
| Meditrina | $135.56 | 2019-2023 | |
| Exeltis, USA INC. | $125.01 | 2020-2025 | Slynd |
| Mayne Pharma Commercial LLC | $75.19 | 2022-2024 | |
| Applied Medical Resources Corporation | $74.00 | 2023 | Gelpoint V-Path |
| Olympus America INC. | $63.96 | 2019-2022 | |
| Medtronic, INC. | $57.30 | 2022 | |
| Intra-Sana Laboratories | $50.00 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Mylan Pharmaceuticals INC. | $33.18 | 2021-2022 | |
| Channel Medsystems, INC. | $32.21 | 2024-2025 | |
| Davol INC. | $31.31 | 2021-2023 | Arista Ah Flexitip |
| Dexcom, INC. | $30.53 | 2025 | Dexcom G6 Transmitter |
| Becton, Dickinson and Company | $30.05 | 2025 | Arista |
| Avanos Medical | $23.87 | 2024 | On-Q* Pump and Accessories |
| Therapeuticsmd, INC. | $23.35 | 2019 | |
| Organon LLC | $23.24 | 2023-2025 | Nexplanon |
| Millicent US INC | $21.21 | 2025 | Femlyv, Intrarosa |
| Lsi Solutions INC | $20.09 | 2025 | Fornisee |
| Avion Pharmaceuticals | $17.89 | 2020 | |
| Exact Sciences Corporation | $17.72 | 2025 | Cologuard Collection Kit |
| Teleflex LLC | $16.57 | 2020 | |
| Boston Scientific Corporation | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$400.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soyini Hawkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.